| A23187 |
Purity: >98%. Effective Concentration: 1-10 μM. A23187, Calcimycin, Ca2+ Ionophore A23187, A23187 is a mobile-carrier Ca2+ ionophore (allows Ca2+ ions to cross cell membranes) originally isolated as an antibiotic from Streptomyces chartreusen... |
10 x 1 mg |
A-600 |
 ALOMONE LABS |
More Info
|
| A23187 |
Purity: >98%. Effective Concentration: 1-10 μM. A23187, Calcimycin, Ca2+ Ionophore A23187, A23187 is a mobile-carrier Ca2+ ionophore (allows Ca2+ ions to cross cell membranes) originally isolated as an antibiotic from Streptomyces chartreusen... |
5 x 5 mg |
A-600 |
 ALOMONE LABS |
More Info
|
| A23187 |
Ca2+ ionophore |
10mg |
Asc-287-10mg |
 ASCENT SCIENTIFIC LTD. |
More Info
|
| A23187 |
Ca2+ ionophore |
50mg |
Asc-287-50mg |
 ASCENT SCIENTIFIC LTD. |
More Info
|
| A77 1726 |
Calbiochem® brand product. |
5mg |
100128 |
 EMD MILLIPORE |
More Info
|
| A-71623 |
Minimum Purity: > 98%. Potent CCK1 agonist (IC50 = 3.7 nM) with 1200-fold selectivity over the CCK2 receptor. Suppresses food intake following central or peripheral administration. |
1mg |
2411 |
 TOCRIS BIOSCIENCE |
More Info
|
| A-769662 |
A-769662 Purity is greater than 99%. |
10 mg |
orb60992 |
 BIORBYT LTD. |
More Info
|
| A-966492 |
A-966492 is a highly potent and efficacious poly(ADP-ribose) polymerase (PARP) inhibitor with a Ki and EC50 of 1 nM. Purity is greater than 99%. |
10 mg |
orb60826 |
 BIORBYT LTD. |
More Info
|
| A23187 |
A calcium ionophore. Causes rapid influx of calcium in various cells. |
10 mg |
1501-10 |
 BIOVISION, INC. |
More Info
|
| A-769662 |
Cell-permeable. A potent AMPK activator. Directly stimulates partially purified rat liver AMPK (EC?? = 0.8 µM) and inhibits fatty acid synthesis in primary rat hepatocytes (IC5?? = 3.2 µM). |
5 mg |
1719-5 |
 BIOVISION, INC. |
More Info
|
| A77 1726 |
Physiologically active metabolite of the immunosuppressive drug leflunomide (Cat. No.1972-10, 50). Inhibits the activity of dihydrorotate dehydrogenase and of protein tyrosine kinases. Blocks TNF-mediated NF-kappaB activation in a dose- and time-d... |
5 mg |
1973-5 |
 BIOVISION, INC. |
More Info
|
| A77 1726 |
Physiologically active metabolite of the immunosuppressive drug leflunomide (Cat. No.1972-10, 50). Inhibits the activity of dihydrorotate dehydrogenase and of protein tyrosine kinases. Blocks TNF-mediated NF-kappaB activation in a dose- and time-d... |
25 mg |
1973-25 |
 BIOVISION, INC. |
More Info
|
| A-71623 |
CCK1 Receptor Agonist |
1 mg |
2411/1 |
 R&D SYSTEMS, INC. |
More Info
|
| AA2 |
n/a |
n/a |
n/a |
 NIH AIDS RESEARCH & REFERENCE REAGENT PROGRAM |
More Info
|
| AA 2414 |
Minimum Purity: > 98%. Thromboxane A2 (TP) receptor antagonist. Antiasthmatic agent; inhibits platelet aggregation and bronchoconstriction induced by a TXA2 mimetic in guinea pigs. |
50mg |
3025 |
 TOCRIS BIOSCIENCE |
More Info
|
| AA 2414 |
Minimum Purity: > 98%. Thromboxane A2 (TP) receptor antagonist. Antiasthmatic agent; inhibits platelet aggregation and bronchoconstriction induced by a TXA2 mimetic in guinea pigs. |
10mg |
3025 |
 TOCRIS BIOSCIENCE |
More Info
|
| AA 29504 |
Minimum Purity: > 98%. Positive allosteric modulator of GABAA receptors. Modulates both alpha4beta3delta-containi ng extrasynaptic receptors and alpha1beta3gamma2S-contai ning receptors in Xenopus oocytes, displaying a stronger modulatory effect at ... |
10mg |
3972 |
 TOCRIS BIOSCIENCE |
More Info
|
| AA 29504 |
Minimum Purity: > 98%. Positive allosteric modulator of GABAA receptors. Modulates both alpha4beta3delta-containi ng extrasynaptic receptors and alpha1beta3gamma2S-contai ning receptors in Xenopus oocytes, displaying a stronger modulatory effect at ... |
50mg |
3972 |
 TOCRIS BIOSCIENCE |
More Info
|
| AA 2414 |
Prostanoid Receptor Antagonist |
10 mg |
3025/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AA 2414 |
Prostanoid Receptor Antagonist |
50 mg |
3025/50 |
 R&D SYSTEMS, INC. |
More Info
|
| AA 29504 |
GABA-A Receptor Modulator |
10 mg |
3972/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AA 29504 |
GABA-A Receptor Modulator |
50 mg |
3972/50 |
 R&D SYSTEMS, INC. |
More Info
|
| AACOCF3 |
Phospholipase-A2 inhibitor |
5mg |
Asc-350-5mg |
 ASCENT SCIENTIFIC LTD. |
More Info
|
| AACOCF3 |
Phospholipase-A2 inhibitor |
25mg |
Asc-350-25mg |
 ASCENT SCIENTIFIC LTD. |
More Info
|
| AACOCF3 |
Calbiochem® brand product. |
10mg |
100109 |
 EMD MILLIPORE |
More Info
|
| AACOCF3 |
Minimum Purity: > 98%. Inhibitor of cytosolic (85 kDa) phospholipase A2. Also inhibits fatty acid amide hydrolase (FAAH, anandamide amidase) in vitro. |
25mg |
1462 |
 TOCRIS BIOSCIENCE |
More Info
|
| AACOCF3 |
Minimum Purity: > 98%. Inhibitor of cytosolic (85 kDa) phospholipase A2. Also inhibits fatty acid amide hydrolase (FAAH, anandamide amidase) in vitro. |
5mg |
1462 |
 TOCRIS BIOSCIENCE |
More Info
|
| AACOCF3 |
Phospholipase Inhibitor |
25 mg |
1462/25 |
 R&D SYSTEMS, INC. |
More Info
|
| AACOCF3 |
Phospholipase Inhibitor |
5 mg |
1462/5 |
 R&D SYSTEMS, INC. |
More Info
|
| 17-AAG |
Purity: >99%. Effective Concentration: 50-100 nM. 17-AAG, An Anticancer Antibiotic. 17-AAG is a less toxic and more stable derivative of the antibiotic Geldanamycin. It binds to Hsp90 and regulates its function. Hsp90 regulates the physiology of c... |
0.1 mg |
A-580 |
 ALOMONE LABS |
More Info
|
| 17-AAG |
Purity: >99%. Effective Concentration: 50-100 nM. 17-AAG, An Anticancer Antibiotic. 17-AAG is a less toxic and more stable derivative of the antibiotic Geldanamycin. It binds to Hsp90 and regulates its function. Hsp90 regulates the physiology of c... |
5 x 0.1 mg |
A-580 |
 ALOMONE LABS |
More Info
|
| 17-AAG |
Calbiochem® brand product. |
500ug |
100068 |
 EMD MILLIPORE |
More Info
|
| 17-AAG |
Glendanamycin (GA), a benzoquinone ansamycin antibiotic, interferes with the action of Hsp90 leading to degradation of Hsp90 client proteins. GA itself however has undesirable properties such as poor aqueous solubility and liver toxicity; therefor... |
1.0mg |
NB110-81558 |
 NOVUS BIOLOGICALS, LLC |
More Info
|
| 17-AAG |
Minimum Purity: > 98%. Inhibitor of heat shock protein 90 (Hsp90) chaperone activity, and an analog of geldanamycin (Cat. No. 1368). Subsequently inhibits the activity of oncogenic proteins such as p185erbB-2 (IC50 = 31 nM), N-ras, Ki-ras and c-Ak... |
1mg |
1515 |
 TOCRIS BIOSCIENCE |
More Info
|
| 17-AAG |
17-AAG Purity is greater than 99%. |
250 mg |
orb60994 |
 BIORBYT LTD. |
More Info
|
| 17-AAG |
Antimicrobial. CAS No.: 75747-14-7 |
n/a |
n/a |
 TOKU-E |
More Info
|
| 17-AAG |
A semi-synthetic derivative of Geldanamycin (Cat. No. 1564-1,5) that displays greater stability and lower in vivo toxicity compared to Geldanamycin. Binds to Heat shock protein 90 (Hsp90) (EC?? = 7.2 µM) in a manner similar to geldanamycin. ... |
1 mg |
1774-1 |
 BIOVISION, INC. |
More Info
|
| 17-AAG |
A semi-synthetic derivative of Geldanamycin (Cat. No. 1564-1,5) that displays greater stability and lower in vivo toxicity compared to Geldanamycin. Binds to Heat shock protein 90 (Hsp90) (EC?? = 7.2 µM) in a manner similar to geldanamycin. ... |
5 mg |
1774-5 |
 BIOVISION, INC. |
More Info
|
| 17-AAG |
HSP90 Inhibitor |
1 mg |
1515/1 |
 R&D SYSTEMS, INC. |
More Info
|
| AAPH |
Calbiochem® brand product. |
1gm |
100110 |
 EMD MILLIPORE |
More Info
|
| ABS 205 |
Minimum Purity: > 98%. Orally active valproic acid (Cat No. 2815) derivative that exhibits teratogenic and neuroprotective activity. Upregulates neural cell adhesion molecule (NCAM) expression, activates PPARdelta (IC50 = 0.6 mM) and increases Hox... |
50mg |
2721 |
 TOCRIS BIOSCIENCE |
More Info
|
| ABS 205 |
Minimum Purity: > 98%. Orally active valproic acid (Cat No. 2815) derivative that exhibits teratogenic and neuroprotective activity. Upregulates neural cell adhesion molecule (NCAM) expression, activates PPARdelta (IC50 = 0.6 mM) and increases Hox... |
10mg |
2721 |
 TOCRIS BIOSCIENCE |
More Info
|
| ABS 205 |
Cell Adhesion Inhibitor |
10 mg |
2721/10 |
 R&D SYSTEMS, INC. |
More Info
|
| ABS 205 |
Cell Adhesion Inhibitor |
50 mg |
2721/50 |
 R&D SYSTEMS, INC. |
More Info
|
| ABCB5 |
Purity: Highly Purified. C-QTQHRNTSKKAQ, from the internal region of the protein sequence according to NP_848654.3.Control peptide corresponding to polyclonal antibody, Catalog#A0004-01C, goat x human.Applications: Suitable for use in ELISA. Other... |
100ug |
A0004-01C-P |
 UNITED STATES BIOLOGICAL |
More Info
|
| Abiraterone |
Abiraterone is a CYP17 inhibitor (IC50 at 4 nM). Purity is greater than 99%. |
10 mg |
orb60159 |
 BIORBYT LTD. |
More Info
|
| Abitrexate |
Abitrexate(Methotrexate) is an antimetabolite and antifolate agent with antineoplastic and immunosuppressant activities. Purity is greater than 99%. |
10 mg |
orb60235 |
 BIORBYT LTD. |
More Info
|
| Abltide |
Peptide sequence (EAIYAAPFAKKK) is based on the C-terminus of Abl. |
1 mg |
A02-58 |
 SIGNALCHEM |
More Info
|
| ABTS |
2 g; 2,2'-Azino-di-[3-ethylben zthiazoline sulfonate (6)] diammonium salt, crystals. Formula: C18H16N4O6S4-(NH4)2Molecu lar weight: ABTS: Mr = 514.6, ABTS-(NH4)2: Mr = 548.7Solubility: soluble in water (c = 50 mg/ml)Note: The green color is due to f... |
n/a |
10102946001 |
ROCHE APPLIED SCIENCE |
More Info
|
| ABT 751 |
Minimum Purity: > 98%. Antimitotic agent, inhibits microtubule polymerization. Binds to beta-tubulin on the colchine site; blocks cell cycle at G2M phase and induces apoptosis. Exhibits antitumor activity. Also displays activity in cell lines resi... |
50mg |
4138 |
 TOCRIS BIOSCIENCE |
More Info
|